2014-05-15 – China Stock Advice

ONP [Orient Paper] 10-Q:

[] [I, Zhenyong Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Orient Paper, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made,] [I, Winston C. Yen, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Orient Paper, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 15, 2014 Zhenyong Liu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 15, 2014 Winston C. Yen Chief Financial Officer (principal financial and accounting officer)]

By info| 2016-03-13T21:16:09+00:00 May 15th, 2014|Categories: Chinese Stocks, ONP, Webplus ver|Tags: 0001358190, 10-Q, 2014-05-15, 2670, CONVERTED PAPER and PAPERBOARD PRODS (NO CONTAINERS/BOXES), ONP|0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x For the quarterly period ended March 31, 2014 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +86 028 8551 6696 (Address, including] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q0314ex32i_tianyin.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director EX-32.2 5 f10q0314ex32ii_tianyin.htm CERTIFICATION]

By info| 2016-03-19T15:35:53+00:00 May 15th, 2014|Categories: Chinese Stocks, SEC Original, TPI|Tags: 0001362718, 10-Q, 2014-05-15, 2834, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments

CBPO [China Biologic Products] 8-K: Amended and Restated Employment Agreement Agreement Company Executive

[Amended and Restated Employment Agreement Agreement Company Executive This Amended and Restated Employment Agreement (this “ Original Agreement WHEREAS, the Company and the Executive entered into an employment agreement dated as of May 11, 2012 (the “ WHEREAS, the term of the Original Agreement will expire on May 11, 2014; and WHEREAS, the Company and the Executive desire to extend] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 11, 2014 CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) 18th Floor, Jialong International Building 19 Chaoyang Park Road Chaoyang District, Beijing 100125 People’s Republic of China 86-10-6598-3166 ____________________________________________________________ (Former name or former]

By info| 2016-03-25T06:22:24+00:00 May 15th, 2014|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: 0001369868, 2014-05-15, 2836, 8-K, BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES), CBPO|0 Comments

CPHI [CHINA PHARMA] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x March 31, 2014 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 15, 2014 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321033114.htm]

By info| 2016-03-28T19:38:04+00:00 May 15th, 2014|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2014-05-15, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

RCON [Recon Technology] 10-Q: (Original Filing)

[] [I, Shenping Yin, certify that: (1) I have reviewed this Form 10-Q of Recon Technology, Ltd; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [Certification of Principal Financial Officer I, Jia Liu, certify that: (1) I have reviewed this Form 10-Q of Recon Technology, Ltd; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Recon Technology, Ltd. Shenping Yin EX-32.1 4 v377246_ex32-1.htm EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Recon Technology, Ltd. Jia Liu Chief Financial Officer (Principal Financial Officer) EX-32.2 5 v377246_ex32-2.htm EX-32.2] [Recon Technology Announces 143% Increase in Third Quarter Revenue BEIJING, May 15, 2014 /PRNewswire/ -- Recon Technology, Ltd. (Nasdaq: RCON) ("Recon" or the "Company"), a Chinese non-state-owned oilfield services provider to oil and gas companies and their affiliates, today reported results for its third quarter of fiscal 2014 ended March 31, 2014. Three Month Financial Highlights: Total revenue for the]

By info| 2016-04-01T16:36:18+00:00 May 15th, 2014|Categories: Chinese Stocks, RCON, SEC Original|Tags: 0001442620, 10-Q, 1389, 2014-05-15, OIL, GAS FIELD SERVICES, NBC, RCON|0 Comments

KGJI [KINGOLD JEWELRY] 10-Q:

[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, Zhihong Jia, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Kingold Jewelry, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, Bin Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Kingold Jewelry, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) Zhihong Jia Chairman, Chief Executive Officer and] [CERTIFICATION OF CHIEF FINANCIAL OFFICER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) Bin Liu Chief Financial Officer and Principal Accounting Officer]

By info| 2016-04-11T01:34:19+00:00 May 15th, 2014|Categories: Chinese Stocks, KGJI, Webplus ver|Tags: 0001089531, 10-Q, 2014-05-15, 7389, KGJI, SERVICES-BUSINESS SERVICES, NEC|0 Comments

JOBS [51JOB] 6-K: (Original Filing)

[51JOB, INC. NOTICE OF EXTRAORDINARY GENERAL MEETING OF MEMBERS NOTICE IS HEREBY GIVEN that the Extraordinary General Meeting of Members (the “Meeting”) of 51job, Inc., a Cayman Islands exempted company (the “Company”), will be held at 9:00 a.m., local time, on June 20, 2014, at the , for the purpose of considering and, if thought fit, passing and approving the] [51JOB, INC. Building 3 No. 1387, Zhang Dong Road Shanghai 201203 People’s Republic of China 2014 EXTRAORDINARY GENERAL MEETING OF MEMBERS TO BE HELD ON JUNE 20, 2014 PROXY STATEMENT The Board of Directors is soliciting proxies for the 2014 Extraordinary General Meeting of Members (the “Meeting”) of 51job, Inc. (the “Company”) to be held on June 20, 2014 at] [51JOB, INC. Incorporated in the Cayman Islands as an exempted company with limited liability ( PROXY FORM AND WRITTEN CONSENT In connection with the (Name) of (Address) (or failing /our proxy for the Meeting and at any adjournment or postponement thereof and to vote all of my/our Shares on my/our behalf as directed below. which, the person chairing the Meeting),] []

By info| 2016-03-15T09:58:54+00:00 May 15th, 2014|Categories: Chinese Stocks, JOBS, SEC Original|Tags: 0001295484, 2014-05-15, 6-K, 7361, JOBS, SERVICES-EMPLOYMENT AGENCIES|0 Comments

TPI [TIANYIN PHARMACEUTICAL] 10-Q: FORM 10-Q (Mark One) x For the quarterly

[FORM 10-Q (Mark One) x For the quarterly period ended March 31, 2014 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of incorporation or organization) Identification No.) 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +86 028 8551 6696 (Address, including] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2014 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q0314ex32i_tianyin.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong Chief Financial Officer, Director EX-32.2 5 f10q0314ex32ii_tianyin.htm CERTIFICATION]

By info| 2016-03-19T15:37:37+00:00 May 15th, 2014|Categories: Chinese Stocks, TPI, Webplus ver|Tags: 0001362718, 10-Q, 2014-05-15, 2834, PHARMACEUTICAL PREPARATIONS, TPI|0 Comments

CLNT [Cleantech Solutions International] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x For the quarterly period ended March 31, 2014 o For the transition period from __________ to __________ CLEANTECH SOLUTIONS INTERNATIONAL, INC. NEVADA 90-0648920 (State or other jurisdiction of incorporation of organization) (I.R.S. Employer Identification No.) No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City Jiangsu Province, China 214181 (86) 51083397559 x o x] [SARBANES-OXLEY ACT OF 2002 I, Jianhua Wu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Cleantech Solutions International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under] [CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER SARBANES-OXLEY ACT OF 2002 I, Adam Wasserman, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Cleantech Solutions International, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Jianhua Wu Chief Executive Officer Adam Wasserman Chief Financial Officer (Principal Accounting Officer) EX-32.1 4 f10q0314ex32i_cleantechsolu.htm CERTIFICATION]

By info| 2016-03-26T12:27:06+00:00 May 15th, 2014|Categories: Chinese Stocks, CLNT, SEC Original|Tags: 0000819926, 10-Q, 2014-05-15, 3550, CLNT, SPECIAL INDUSTRY MACHINERY (NO METALWORKING MACHINERY)|0 Comments

CPHI [CHINA PHARMA] 10-Q: FORM 10-Q (Mark One) x March 31, 2014

[FORM 10-Q (Mark One) x March 31, 2014 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 15, 2014 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321033114.htm]

By info| 2016-03-28T19:39:39+00:00 May 15th, 2014|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2014-05-15, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments